Prudential Financial
TAK icon

Prudential Financial’s Takeda Pharmaceutical TAK Stock Holding History

Prudential Financial’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,653
Closed -$151K – 2681
2024
Q3 		$151K Buy
10,653
+570
+6% +$8.09K ﹤0.01% 2543
2024
Q2 		$130K Sell
10,083
-3,007
-23% -$39.8K ﹤0.01% 2530
2024
Q1 		$182K Buy
13,090
+142
+1% +$2.06K ﹤0.01% 2482
2023
Q4 		$185K Sell
12,948
-40
-0.3% -$568 ﹤0.01% 2453
2023
Q3 		$201K Buy
+12,988
New +$201K ﹤0.01% 2394

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Prudential Financial's TAK Position: Q4 2024 in Review

Prudential Financial sold out of Takeda Pharmaceutical (TAK) in Q4 2024, closing a stake of 10,653 shares — an estimated $151K sold.

Prudential Financial first reported a position in TAK in Q3 2023 and held it in 5 quarters. The position peaked at $201K in Q3 2023. 299 funds tracked by Wall St. Rank hold TAK as of Q4 2024.

  • Prudential Financial reported no remaining Takeda Pharmaceutical position as of Q4 2024 after selling out during the quarter.
  • Prudential Financial sold 10,653 Takeda Pharmaceutical shares in Q4 2024, an estimated $151K.
  • Prudential Financial first reported a position in Takeda Pharmaceutical in Q3 2023 and held it in 5 quarters.
  • Prudential Financial's Takeda Pharmaceutical position peaked at $201K in Q3 2023.
  • 299 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2024.

Based on Prudential Financial's 13F filing for Q4 2024, filed 11 Feb 2025.